ZURICH, Switzerland, April 29, 2022 (GLOBE NEWSWIRE) — Ad hoc announcement pursuant to Art. 53LR – Achiko SA (SIX: ACHI; OTCQB: ACHKF; ISIN CH0522213468) (“Achiko”, the “Company”) announces that Achiko will publish its annual report and annual financial statements for the year 2021 on May 31, 2022 at the latest. As a SIX-listed company, Achiko is required to publish its annual report, as well as annual financial statements, within four months of the balance sheet date. Due to the Covid-19 pandemic, new staff and training under difficult conditions following the measures taken by several countries required a great deal of management capacity. Accordingly, the publication of the annual report, as well as the annual financial statements, as of December 31, 2021, will take place in the month of May 2022. Achiko has filed an exemption request with SIX Exchange Regulation (SER) regarding the publication of the report 2021 Annual Report and Annual Accounts. On April 28, 2022, SER granted Achiko the requested extension.
As required by SER, Achiko hereby reprints par. I of the respective decision of the SER:
| I. | Achiko’s (issuer) waiver request dated April 27, 2022, requesting an extension of the deadline for publishing its 2021 annual report and filing this report with SIX Exchange Regulation AG until May 31, 2022 at the latest later, is granted with the following reservation (lit. a) and under the following conditions (lit. b and c): | |||
| a. | SIX Exchange Regulation AG reserves the right to suspend trading in the issuer’s registered shares if its annual report 2021 is not published in accordance with the provisions on ad hoc publicity (Art. 53 of the Listing Regulations [LR] in connection with the directive on event advertising [DAH]) and filed with SIX Exchange Regulation AG by Tuesday, May 31, 2022, 11:59 p.m. CET, at the latest. | |||
| b. | Achiko is required to publish a notice in accordance with the provisions on event advertising (art. 53 LR in relation to the DAH) concerning this decision until Friday, April 29, 2022, 7:30 a.m. CET, at the latest. The notice must contain: | |||
| – | the unchanged reproduction of the wording of s. I. of this decision, placed in first place; | |||
| – | the reasons for the issuer’s request for an extension of the deadline for publishing its 2021 annual report and for filing this report with SIX Exchange Regulation AG. | |||
| vs. | Achiko is required to publish a notice in accordance with the provisions on event advertising (art. 53 LR in relation to the DAH) concerning this decision until Thursday, May 19, 2022, 7:30 a.m. CET, at the latest. The notice must contain: | |||
| – | unaudited key figures such as net income, EBITDA, EBIT, result, balance sheet total, equity, etc. for the 2021 annual results. | |||
The next Annual General Meeting was scheduled to take place on May 31, 2022. Due to the subsequent publication of the 2021 Annual Report, the 2022 Annual General Meeting will take place at the end of June 2022.
ABOUT ACHIKO AG
Achiko AG (SIX: ACHI.SW; OTCQB: ACHKF; www.achiko.com) develops breakthrough diagnostic solutions that put people first. The company’s flagship product is a fast and reliable Covid-19 test with a companion app offering a user-friendly digital health passport. The test and companion app were launched in Indonesia in mid-2021 and an application for CE mark approval in Europe will be submitted in 2022.
Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameXMT and complementary health apps through its digital mobile health technology division, Teman SehatMT. AptameX DNA aptamer assays can be rapidly chemically synthesized, are cost effective and have broad potential for the diagnosis of several diseases. Leveraging AptameX and Teman Sehat, Achiko aims to provide rapid, accurate and affordable diagnostic tests for a range of pathogenic diseases and therapeutic indications in the rapidly evolving field of healthcare diagnostics.
Based in Zurich, Achiko has offices in Jakarta and staff worldwide.
Media contacts:
ACHIKO S.A.
Investor Relations
E: ir@achiko.com
Switzerland and the world
Marcus Balogh
Farner Consulting Ltd.
E: achiko@farner.ch
Such. : +41 44 266 67 67
Warning
This communication expressly or implicitly contains certain forward-looking statements regarding Achiko AG and its business. These statements involve certain known and unknown risks, uncertainties and other factors, which could cause the actual results, financial condition, performance or achievements of Achiko AG to be materially different from future results, performance or achievements. expressed or implied by these statements. research statements. Achiko AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
